APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence
Status:
Terminated
Trial end date:
1999-03-01
Target enrollment:
Participant gender:
Summary
Experimental and epidemiologic studies have suggested that aspirin intake reduces the risk
for colorectal cancer. In the APACC study we randomly assigned 291 patients to daily Aspirin
or Placebo for 4 years. However, the available data are not sufficient to serve as the basis
for firm recommendations
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
Ministry of Health, France Sanofi-Synthelabo Société Nationale Française de Gastroentérologie